13.4 Accreditation Standards & Outcomes of APRN Practice
Key Takeaways
- Commission on Cancer accreditation requires a cancer committee, an annual cancer registry, multidisciplinary conferences, guideline-concordant care, psychosocial distress screening, survivorship services, and palliative care access.
- NCI designation is a research designation with three tiers, and Comprehensive status requires depth and breadth across basic, clinical, and population science plus community outreach and engagement.
- FACT accreditation applies specifically to hematopoietic cell therapy and immune effector cell programs and governs collection, processing, and clinical care standards.
- Donabedian's framework classifies quality measures as structure, process, or outcome, and process measures dominate oncology quality programs because outcomes require long follow-up and heavy risk adjustment.
- APRN-sensitive outcomes include time to treatment initiation, symptom management response, unplanned emergency department visits and admissions, advance care planning documentation, distress screening completion, and trial enrollment rates.
13.4 Accreditation Standards & Outcomes of APRN Practice
Blueprint focus: ONCC Domain V.C (accreditation standards, e.g. Commission on Cancer, National Cancer Institute, FACT), V.F (outcomes of APRN interventions and evidence-based care on individuals, groups, and systems), and V.G (quality improvement strategies).
The Accreditation Landscape
| Body | What it accredits | Core requirements the APRN encounters |
|---|---|---|
| Commission on Cancer (CoC), a program of the American College of Surgeons | Cancer programs — hospitals and cancer centers | Multidisciplinary cancer committee; a maintained cancer registry with annual reporting and follow-up; regular multidisciplinary case conferences; guideline-concordant treatment; psychosocial distress screening; survivorship program services; palliative care access; clinical trial accrual; annual quality studies |
| National Cancer Institute (NCI) | Research capacity at cancer centers | Three tiers: Basic Laboratory, Cancer Center, and Comprehensive Cancer Center. Comprehensive status requires depth and breadth across basic, clinical, and population sciences plus community outreach and engagement and demonstrated transdisciplinary collaboration. NCI designation is about research infrastructure, not about clinical accreditation of care delivery |
| FACT (Foundation for the Accreditation of Cellular Therapy) | Hematopoietic cell therapy and immune effector cell programs | Standards spanning clinical program, collection facility, and processing facility; personnel qualification and training; quality management; outcome reporting; CAR T-cell and other immune effector cell-specific standards |
| ASCO QOPI® (Quality Oncology Practice Initiative) | Oncology practices | Voluntary measure-based self-assessment with QOPI Certification available; measures include staging documentation before treatment, biomarker testing before targeted therapy, chemotherapy consent, pain and emesis assessment at each visit, antiemetic guideline concordance, and timely palliative care referral |
| ONS | Nursing practice standards | Chemotherapy and immunotherapy administration standards, safe handling, and competency frameworks; jointly published with ASCO for chemotherapy administration safety |
| The Joint Commission | Hospitals and health systems | National Patient Safety Goals; medication management; the Universal Protocol; disease-specific care certification |
| ANCC Magnet Recognition | Nursing excellence at the organization level | Transformational leadership, structural empowerment, exemplary professional practice, new knowledge and innovation, and empirical outcomes — which requires nurse-sensitive outcome data |
| NCCN Member Institutions | Guideline-developing institutions | Not an accreditation program, though frequently confused with one |
The distinction most often tested: CoC accredits care delivery, NCI designates research capacity, and FACT accredits cell therapy programs. A hospital can be CoC-accredited without being NCI-designated, and vice versa.
The Donabedian Framework
Quality measures fall into three categories.
| Type | Definition | Oncology examples |
|---|---|---|
| Structure | The setting and resources | Board-certified staffing ratios, availability of an oncology pharmacist, presence of an infusion safety program, electronic health record capability |
| Process | What is actually done | Percentage of patients with stage documented before treatment, antiemetic guideline concordance, distress screening completion rate, time from diagnosis to treatment |
| Outcome | What happens to the patient | Survival, unplanned admission rate, patient-reported symptom burden, treatment-related mortality, patient experience |
Most oncology quality programs are dominated by process measures, because outcomes take years to mature and require heavy risk adjustment that small practices cannot perform. Process measures are actionable and attributable; outcome measures are what patients actually care about. A good quality program uses both.
Outcomes of APRN Practice
Domain V.F asks specifically about the effect of APRN interventions at three levels.
Individual level. Symptom control, functional status, adherence, patient experience, self-management capability, and goal-concordant care.
Group and population level. Reduced time to treatment initiation, higher rates of guideline-concordant care, higher distress screening and survivorship care plan completion, higher advance care planning documentation, higher clinical trial screening and enrollment, and reduced disparities in these measures across subgroups.
System level. Reduced unplanned emergency department visits and hospital admissions, shortened length of stay, improved access and clinic throughput, cost avoidance, and improved continuity across care transitions.
Evidence base. APRN-led oncology care has repeatedly demonstrated outcomes comparable to physician-delivered care for survivorship follow-up, symptom management, and chronic disease management, with equal or higher patient satisfaction. APRN-led symptom triage and telephone or remote monitoring programs reduce avoidable emergency department utilization. Early palliative care delivered substantially by advanced practice clinicians improves quality of life, reduces depressive symptoms, and in the landmark metastatic NSCLC trial was associated with less aggressive end-of-life care and longer survival.
Measuring your own contribution is a professional obligation, not an optional exercise. Choose measures you can actually attribute: time to treatment initiation for your panel, percentage of your patients with a documented survivorship care plan, unplanned admissions among patients enrolled in your symptom-monitoring program, distress screening completion, advance care planning documentation, and trial screening rates.
Quality Improvement Methods
| Method | Nature | Use |
|---|---|---|
| PDSA (Plan-Do-Study-Act) | Iterative small-scale testing | Rapid-cycle improvement of a defined process |
| Lean | Waste elimination and flow | Clinic throughput, chemotherapy turnaround, reducing waiting |
| Six Sigma (DMAIC) | Variation reduction | Standardizing high-variability, error-prone processes |
| Root cause analysis (RCA) | Retrospective | Investigating a sentinel event or near miss to find latent system flaws rather than individual blame |
| Failure mode and effects analysis (FMEA) | Prospective | Identifying failure points before implementing a new process, such as a new CAR T-cell pathway |
RCA versus FMEA is a recurring exam item. RCA looks backward at an event that happened; FMEA looks forward at an event you are trying to prevent.
Quality improvement is not human subjects research. QI aims to improve local care using existing evidence and generally does not require IRB approval, though intent to generate generalizable knowledge and publish can move a project into research territory — when in doubt, ask the IRB rather than assume.
Value-Based Payment in Oncology
- Oncology Care Model (OCM) and its successor the Enhancing Oncology Model (EOM) are CMS episode-based payment models tying payment to quality and total cost of care during a chemotherapy episode. Both require the IOM/NASEM 13-point care management plan, 24/7 access to a clinician with real-time medical record access, patient navigation, and continuous quality improvement — all of which are work the oncology APRN performs.
- MIPS (Merit-based Incentive Payment System) adjusts Medicare payment based on quality, cost, improvement activities, and interoperability.
- CMS Oncology Care measures include chemotherapy administered in the last 14 days of life, hospice enrollment for fewer than 3 days before death, and emergency department utilization — all measures the APRN can move directly through advance care planning and proactive symptom management.
Understanding which measures the practice is judged on tells you where APRN effort will be visible in the data, which is how quality improvement work becomes sustainable rather than voluntary.
A hospital is preparing for Commission on Cancer accreditation survey. Which of the following is a CoC requirement the oncology nurse practitioner is likely to be directly responsible for?
An oncology practice is planning to implement a new outpatient CAR T-cell therapy pathway and wants to identify potential failure points before the first patient is treated. Which quality improvement method is appropriate?
Which of these is an outcome measure rather than a process measure under the Donabedian framework?